C Jan Willem Borleffs
Overview
Explore the profile of C Jan Willem Borleffs including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
82
Citations
2634
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yang M, Kondo T, Jhund P, Alcocer-Gamba M, Borleffs C, Chiang C, et al.
Eur J Heart Fail
. 2024 Jun;
26(8):1788-1803.
PMID: 38923118
Aims: Compared to heart failure (HF) with reduced ejection fraction, HF with preserved ejection fraction (HFpEF), and HF with mildly reduced ejection fraction (HFmrEF) are increasing in prevalence, yet little...
2.
Allach Y, Barry-Loncq de Jong M, Clephas P, van Gent M, Brunner-La Rocca H, Szymanski M, et al.
Eur J Heart Fail
. 2024 Jun;
26(8):1736-1744.
PMID: 38825743
Aims: Heart failure (HF), a global pandemic affecting millions of individuals, calls for adequate predictive guidance for improved therapy. Congestion, a key factor in HF-related hospitalizations, further underscores the need...
3.
Malgie J, Wilde M, Clephas P, Emans M, Koudstaal S, Schaap J, et al.
Eur J Heart Fail
. 2024 May;
26(7):1549-1560.
PMID: 38734980
Aims: Despite clear guideline recommendations for initiating four drug classes in all patients with heart failure (HF) with reduced ejection fraction (HFrEF) and the availability of rapid titration schemes, information...
4.
Clephas P, Zwartkruis V, Malgie J, van Gent M, Brunner-La Rocca H, Szymanski M, et al.
Eur Heart J
. 2024 May;
45(32):2954-2964.
PMID: 38733175
Background And Aims: In patients with chronic heart failure (HF), the MONITOR-HF trial demonstrated the efficacy of pulmonary artery (PA)-guided HF therapy over standard of care in improving quality of...
5.
Clephas P, Malgie J, Schaap J, Koudstaal S, Emans M, Linssen G, et al.
ESC Heart Fail
. 2023 Dec;
11(1):550-559.
PMID: 38064176
Aims: Current heart failure (HF) guidelines recommend to prescribe four drug classes in patients with HF with reduced ejection fraction (HFrEF). A clear challenge exists to adequately implement guideline-directed medical...
6.
Brugts J, Radhoe S, Clephas P, Aydin D, van Gent M, Szymanski M, et al.
Lancet
. 2023 May;
401(10394):2113-2123.
PMID: 37220768
Background: The effect of haemodynamic monitoring of pulmonary artery pressure has predominantly been studied in the USA. There is a clear need for randomised trial data from patients treated with...
7.
Peikert A, Chandra A, Kosiborod M, Claggett B, Desai A, Jhund P, et al.
JAMA Cardiol
. 2023 May;
8(7):684-690.
PMID: 37208998
Importance: Dapagliflozin has been shown to improve overall health status based on aggregate summary scores of the Kansas City Cardiomyopathy Questionnaire (KCCQ) in patients with heart failure (HF) with mildly...
8.
Kondo T, Jering K, Borleffs C, de Boer R, Claggett B, Desai A, et al.
Circulation
. 2023 Mar;
147(14):1067-1078.
PMID: 36876483
Background: How patient characteristics and outcomes vary according to the duration of heart failure (HF) is unknown in individuals with mildly reduced or preserved ejection fraction. We compared these, and...
9.
Saleem-Talib S, van Driel V, Nikolic T, van Wessel H, Louman H, Borleffs C, et al.
Pacing Clin Electrophysiol
. 2022 Aug;
45(10):1248-1254.
PMID: 36031774
Aims: To evaluate safety of leadless pacemaker implantation through the internal jugular vein in a larger cohort with longer follow-up. Moreover, feasibility of non-apical pacing as well as relation between...
10.
Solomon S, McMurray J, Claggett B, de Boer R, DeMets D, Hernandez A, et al.
N Engl J Med
. 2022 Aug;
387(12):1089-1098.
PMID: 36027570
Background: Sodium-glucose cotransporter 2 (SGLT2) inhibitors reduce the risk of hospitalization for heart failure and cardiovascular death among patients with chronic heart failure and a left ventricular ejection fraction of...